Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment

Neurology
Esther S C KorfPhilip Scheltens

Abstract

Although detailed volumetric MRI assessment of medial temporal lobe atrophy (MTA) can predict dementia in patients with mild cognitive impairment (MCI), it is not easily applied to routine clinical practice. To test the predictive accuracy of visually assessed MTA in MCI patients using a standardized visual rating scale. Seventy-five MCI patients (mean age 63 years) underwent a coronal three-dimensional magnetization-prepared rapid gradient echo brain MRI sequence. MTA was rated visually using a 5-point rating scale. The mean follow-up period for the cohort was 34 months. At follow-up, 49% of the enrolled MCI patients fulfilled criteria for dementia. MTA assessed using a standardized visual rating scale was significantly associated with dementia at follow-up, with a hazard ratio of 1.5 for every point increase in atrophy score (p < 0.001) and of 3.1 for the presence of atrophy based on the dichotomized atrophy score (p = 0.003). The predictive accuracy of visually assessed MTA was independent of age, gender, education, Mini-Mental State Examination score, Clinical Dementia Rating Sum of Boxes score, Verbal Delayed Recall, and the presence of hypertension, depression, the APOE epsilon4 allele, and white matter hyperintensities. ...Continue Reading

Citations

Jun 27, 2013·European Journal of Nuclear Medicine and Molecular Imaging·A BrückJ O Rinne
Jul 26, 2006·European Radiology·Stéphane LehéricySerge Kinkingnehun
Feb 19, 2009·European Archives of Psychiatry and Clinical Neuroscience·Breno Satler DinizOrestes Vicente Forlenza
Jan 5, 2010·Journal of Neurology·John Matthew RingmanNoriko Salamon
Jun 1, 2009·Brain Imaging and Behavior·Richard D KingUNKNOWN the Alzheimer’s Disease Neuroimaging Initiative
Oct 30, 2009·Psychological Medicine·B SchmandW A van Gool
Jul 16, 2011·Development and Psychopathology·Robert-Paul JusterSonia J Lupien
May 25, 2007·Journal of the International Neuropsychological Society : JINS·Deborah A Cahn-WeinerHelena Chui
Feb 9, 2010·Nature Reviews. Neurology·Giovanni B FrisoniPaul M Thompson
Jan 9, 2013·Nature Reviews. Neurology·Chia-Chen LiuGuojun Bu
Dec 22, 2006·The New England Journal of Medicine·Gary W SmallJorge R Barrio
May 15, 2009·Brain : a Journal of Neurology·Olivier QuerbesUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 16, 2006·The Gerontologist·Jennifer Hagerty LinglerSteven T DeKosky
Jun 9, 2005·Alzheimer Disease and Associated Disorders·John C Morris
May 29, 2009·Alzheimer Disease and Associated Disorders·Sanja KovacevicUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jul 3, 2009·Alzheimer Disease and Associated Disorders·Ariadna BesgaTomás Ortiz
Apr 5, 2012·Cold Spring Harbor Perspectives in Medicine·Keith A JohnsonWilliam E Klunk
Nov 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·W M van der Flier, P Scheltens
Mar 22, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·F PortetUNKNOWN MCI Working Group of the European Consortium on Alzheimer's Disease (EADC)
Jun 7, 2005·Postgraduate Medical Journal·R Vandenberghe, J Tournoy
Sep 24, 2005·Dementia and Geriatric Cognitive Disorders·Esther S C KorfFrank-Erik de Leeuw
Jan 16, 2007·Dementia and Geriatric Cognitive Disorders·Roberta RossiGiovanni B Frisoni
Aug 19, 2007·Dementia and Geriatric Cognitive Disorders·Edmond TengJeffrey L Cummings
Feb 12, 2008·Dementia and Geriatric Cognitive Disorders·Claudia JacovaHoward H Feldman
Jul 5, 2012·Dementia and Geriatric Cognitive Disorders·Ningnannan ZhangUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 19, 2013·Dementia and Geriatric Cognitive Disorders·Suvarna AlladiSubhash Kaul
Sep 29, 2012·Neurology·Ineke A van RossumPieter Jelle Visser
Jun 2, 2011·International Journal of Alzheimer's Disease·Jonghan ShinJorge R Barrio
Mar 15, 2014·Journal of Molecular Neuroscience : MN·Nadia El KadmiriSellama Nadifi
Jan 10, 2013·Annual Review of Clinical Psychology·Shannon L Risacher, Andrew J Saykin
Nov 29, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Lisa MosconiMony J de Leon
Aug 2, 2011·European Radiology·Esther L G E KoedamMike P Wattjes
Aug 24, 2013·Neurología : publicación oficial de la Sociedad Española de Neurología·J A Monge ArgilésC Leiva Santana
Aug 17, 2014·L'Encéphale·N El KadmiriB El Moutawakil
Jul 26, 2014·The British Journal of Radiology·V DhikavK S Anand
Jan 16, 2014·International Review of Psychiatry·Marion MortamaisKaren Ritchie

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.